Table-III.
Group | n | cTnI (ρB/ng/ml) | CK-MB | △ MPO | △ hs-CRP |
---|---|---|---|---|---|
Control | 238 | 0.631±0.472 | 25.1±3.6 | 38.8±19.5 | 5.60±6.33 |
Experiment | 237 | 0.384±0.527* | 25.7±2.6 | 15.7±25.2* | 5.29±8.17 |
* P< 0.05, compared to the control group.
Group | n | cTnI (ρB/ng/ml) | CK-MB | △ MPO | △ hs-CRP |
---|---|---|---|---|---|
Control | 238 | 0.631±0.472 | 25.1±3.6 | 38.8±19.5 | 5.60±6.33 |
Experiment | 237 | 0.384±0.527* | 25.7±2.6 | 15.7±25.2* | 5.29±8.17 |
* P< 0.05, compared to the control group.